Sonoma Pharmaceuticals (SNOA) EBITDA Margin Growth (1y) (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,665.00 |
| Mar 31, 2026 | 1,116.00 |
| Dec 31, 2025 | 1,334.00 |
| Sep 30, 2025 | 1,774.00 |
| Jun 30, 2025 | 732.00 |
| Mar 31, 2025 | 2,350.00 |
| Dec 31, 2024 | -203.00 |
| Sep 30, 2024 | 2,048.00 |
| Jun 30, 2024 | 159.00 |
| Mar 31, 2024 | -292.00 |
| Dec 31, 2023 | 3,540.00 |
| Sep 30, 2023 | -2,229.00 |
| Jun 30, 2023 | -1,472.00 |
| Mar 31, 2023 | 9,510.00 |
| Dec 31, 2022 | -2,928.00 |
| Sep 30, 2022 | 380.00 |
| Jun 30, 2022 | 307.00 |
| Mar 31, 2022 | -270.00 |
| Dec 31, 2021 | -3,022.00 |
| Sep 30, 2021 | -2,868.00 |